Camber Pharma Launches Generic Maxalt®
Piscataway, NJ, February 3, 2015– Camber Pharmaceuticals announces that it has launched Rizatriptan Benzoate 5mg and 10mg tablets. The drug is the generic version of Maxalt® tablets. Rizatriptan is used to treat migraine headaches.
Rizatriptan is available in an 18 count blister pack for both 5mg and 10mg.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection